| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-12 01:12:16 UTC |
|---|
| Updated at | 2022-09-12 01:12:17 UTC |
|---|
| NP-MRD ID | NP0322440 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (3e)-4-ethyl-2-(hydroxyimino)-5-nitrohex-3-enimidic acid |
|---|
| Description | FK409, also known as nor-3 CPD, belongs to the class of organic compounds known as ketoximes. These are organic compounds with the general formula RC(R')=NOH (R,R' = organyl). (3e)-4-ethyl-2-(hydroxyimino)-5-nitrohex-3-enimidic acid is found in Streptomyces griseosporeus. (3e)-4-ethyl-2-(hydroxyimino)-5-nitrohex-3-enimidic acid was first documented in 2007 (PMID: 17959957). Based on a literature review a small amount of articles have been published on FK409 (PMID: 25152034) (PMID: 22387484) (PMID: 19000699) (PMID: 18391852). |
|---|
| Structure | CC\C(=C/C(=NO)C(O)=N)C(C)[N+]([O-])=O InChI=1S/C8H13N3O4/c1-3-6(5(2)11(14)15)4-7(10-13)8(9)12/h4-5,13H,3H2,1-2H3,(H2,9,12)/b6-4+,10-7? |
|---|
| Synonyms | | Value | Source |
|---|
| 4-Ethyl-2-(hydroxyimino)-5-nitro-3-hexenamide | MeSH | | 4-Ethyl-2-hydroxyimino-5-nitro-3-hexenamide | MeSH | | 4-Ethyl-2-hydroxyimino-5-nitro-3-hexenecarboxamide | MeSH | | NOR-3 CPD | MeSH | | NOR3 hexenamide CPD | MeSH | | Ethyl-2-(hydroxyamino)-5-nitro-3-hexenamide | MeSH |
|
|---|
| Chemical Formula | C8H13N3O4 |
|---|
| Average Mass | 215.2090 Da |
|---|
| Monoisotopic Mass | 215.09061 Da |
|---|
| IUPAC Name | (3E)-4-ethyl-2-(hydroxyimino)-5-nitrohex-3-enimidic acid |
|---|
| Traditional Name | (3E)-4-ethyl-2-(hydroxyimino)-5-nitrohex-3-enimidic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC\C(=C/C(=NO)C(O)=N)C(C)[N+]([O-])=O |
|---|
| InChI Identifier | InChI=1S/C8H13N3O4/c1-3-6(5(2)11(14)15)4-7(10-13)8(9)12/h4-5,13H,3H2,1-2H3,(H2,9,12)/b6-4+,10-7? |
|---|
| InChI Key | MZAGXDHQGXUDDX-MXRGZUMGSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as ketoximes. These are organic compounds with the general formula RC(R')=NOH (R,R' = organyl). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic nitrogen compounds |
|---|
| Class | Organonitrogen compounds |
|---|
| Sub Class | Oximes |
|---|
| Direct Parent | Ketoximes |
|---|
| Alternative Parents | |
|---|
| Substituents | - Ketoxime
- Carboxamide group
- C-nitro compound
- Organic nitro compound
- Primary carboxylic acid amide
- Carboxylic acid derivative
- Organic oxoazanium
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Allyl-type 1,3-dipolar organic compound
- Carbonyl group
- Organic zwitterion
- Organooxygen compound
- Organic salt
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Ueshima S, Nishida T, Koike M, Matsuda H, Sawa Y, Uchiyama Y: Nitric oxide-mediated injury of interstitial cells of Cajal and intestinal dysmotility under endotoxemia of mice. Biomed Res. 2014;35(4):251-62. doi: 10.2220/biomedres.35.251. [PubMed:25152034 ]
- Ruef P, Craciun E, Frommhold D, Kuss N, Fritzsching B, Poschl J, Koch L: The NO-donor FK409 improves mechanical properties of activated neonatal PMN. Clin Hemorheol Microcirc. 2012;51(4):293-301. doi: 10.3233/CH-2012-1536. [PubMed:22387484 ]
- Ito Y, Okuda S, Ohkawa F, Kato S, Mitsufuji S, Yoshikawa T, Takeuchi K: Dual role of nitric oxide in gastric hypersecretion in the distended stomach: inhibition of acid secretion and stimulation of pepsinongen secretion. Life Sci. 2008 Dec 19;83(25-26):886-92. doi: 10.1016/j.lfs.2008.10.010. Epub 2008 Oct 30. [PubMed:19000699 ]
- Wang Y, Crisostomo PR, Wang M, Weil B, Abarbanell A, Poynter J, Manukyan MC, Meldrum DR: Nitric oxide suppresses the secretion of vascular endothelial growth factor and hepatocyte growth factor from human mesenchymal stem cells. Shock. 2008 Nov;30(5):527-31. doi: 10.1097/SHK.0b013e31816f1ec9. [PubMed:18391852 ]
- Guarda IF, Saad WA, de Arruda Camargo LA: Nitric oxide and angiotensin II receptors mediate the pressor effect of angiotensin II: a study in conscious and zoletil-anesthetized rats. Anesth Analg. 2007 Nov;105(5):1293-7, table of contents. doi: 10.1213/01.ane.0000282782.30891.c5. [PubMed:17959957 ]
- LOTUS database [Link]
|
|---|